Topical treatment of cutaneous Kaposi sarcoma with imiquimod 5% in renal-transplant recipients: A clinicopathological observation

Clinical and Experimental Dermatology

Volumn 37, Issue 6, 2012, Pages 620-625

  Prinz Vavricka, B M ^a   Hofbauer, G F L ^a   Dummer, R ^a   French, L E ^a   Kempf, W ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; IMIQUIMOD; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER REGRESSION; CASE REPORT; ERYTHEMA; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY INFILTRATE; KAPOSI SARCOMA; KIDNEY GRAFT; LYMPH NODE METASTASIS; LYMPHOCYTE; MALE; MERKEL CELL TUMOR; PRIORITY JOURNAL; SKIN BIOPSY; ULCER;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, TOPICAL; AGED; AMINOQUINOLINES; ANTIGENS, CD; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; SARCOMA, KAPOSI; SKIN NEOPLASMS;

EID: 84864142593     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2011.04278.x     Document Type: Article

References (24)

1. Hengge UR, Ruzicka T, Tyring SK, et al. Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 1: epidemiology, environmental predispositions, clinical manifestation, and therapy. Lancet Infect Dis 2002; 2: 281-92.
2. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266: 1865-9.
3. Penn I,. Sarcomas in organ allograft recipients. Transplantation 1995; 60: 1485-91.
4. Dreno B,. Skin cancers after transplantation. Nephrol Dial Transplant 2003; 18: 1052-8.
5. Ozen S, Saatci U, Karaduman A, et al. Kaposi's sarcoma in a paediatric renal transplant recipient. Nephrol Dial Transplant 1996; 11: 1162-3.
6. Frances C,. Kaposi's sarcoma after renal transplantation. Nephrol Dial Transplant 1998; 13: 2768-73.
7. Stallone G, Schena A, Infante B, et al. Sirolimus for Kaposi's sarcoma in renal-transplant recipients. N Engl J Med 2005; 352: 1317-23.
8. Einollahi B,. Kaposi sarcoma after kidney transplantation. Iran J Kidney Transplant 2007; 1: 2-11.
9. Dockrell DH, Kinghorn GR,. Imiquimod and resiquimod as novel immunomodulators. J Antimicrob Chemother 2001; 48: 751-5.
10. Urosevic M, Dummer R, Conrad C, et al. Disease-independent skin recruitment and activation of plasmacytoid predendritic cells following imiquimod treatment. J Natl Cancer Inst 2005; 97: 1143-53.
11. Kazakov DV, Prinz BM, Michaelis S, et al. Study of HHV-8 DNA sequences in archival biopsies from lesional skin of Kaposi's sarcoma, various mesenchymal tumors and related reactive conditions. J Cutan Pathol 2002; 29: 279-81.
12. Penn I,. Kaposi's sarcoma in transplant recipients. Transplantation 1997; 64: 669-73.
13. Euvrard S, Kanitakis J, Claudy A,. Skin cancers after organ transplantation. N Engl J Med 2003; 348: 1681-91.
14. Euvrard S, Kanitakis J, Bosshard C, et al. No recurrence of posttransplantation Kaposi's sarcoma three years after renal retransplantation. Transplantation 2002; 73: 297-9.
15. Woodle E, Hanaway M, Buell J, et al. Israel Penn Transplant Tumor Registry. Kaposi's sarcoma: an analysis of the US and international experiences from the Israel Penn International Transplant Tumor Registry. Transplant Proc 2001; 33: 3660-1.
16. Hofbauer GFL, Bouwes Bavinck JN, Euvrard S,. Organ transplantation and skin cancer: basic problems and new perspectives. Exp Dermatol 2010; 19: 473-82.
17. Campistol JM, Gutierrez-Dalmau A, Torregrosa JV,. Conversion to sirolimus: a successful treatment for posttransplantation Kaposi's sarcoma. Transplantation 2004; 77: 760-2.
18. Stockfleth E, Ulrich C, Meyer T, Christophers E,. Epithelial malignancies in organ transplant patients: clinical presentation and new methods of treatment. Recent Results Cancer Res 2002; 160: 251-8.
19. Ulrich C, Bichel J, Euvrard S, et al. Topical immunomodulation under systemic immunosuppression: results of a multicentre, randomized, placebo-controlled safety and efficacy study of imiquimod 5% cream for the treatment of actinic keratoses in kidney, heart, and liver transplant patients. Br J Dermatol 2007; 157: 25-31.
20. Célestin Schartz NE, Chevret S, Paz C, et al. Imiquimod 5% cream for treatment of HIV-negative Kaposi's sarcoma skin lesions: a phase I to II, open-label trial in 17 patients. J Am Acad Dermatol 2008; 58: 585-91.
21. Goiriz R, Ríos-Buceta L, De Arriba AG, et al. Treatment of classic Kaposi's sarcoma with topical imiquimod. Dermatol Surg 2009; 35: 147-9.
22. Rosen T,. Limited extent AIDS-related cutaneous Kaposi's sarcoma responsive to imiquimod 5% cream. Int J Dermatol 2006; 45: 854-6.
23. Babel N, Eibl N, Ulrich C, et al. Development of Kaposi's sarcoma under sirolimus-based immunosuppression and successful treatment with imiquimod. Transpl Infect Dis 2008; 10: 59-62.
24. Echeverría-García B, Sanmartín O, Guillén C,. [Clinical remission of classic Kaposi sarcoma with topical 5% imiquimod] (in Spanish). Actas Dermosifiliogr 2010; 101: 181-2.